Denna sida på svenska
Loading profile information...

About me

I am a mathematical statistician by training who have been working as an applied statistician at Karolinska Institutet for more than ten years. Since 2013 I have been working in close collaboration with Karin Ekström Smedby in the cancer epidemiology group at the Clinical Epidemiology Unit.

My main tasks include providing statistical expertise (design, analysis and interpretation) in epidemiological studies, supervising doctoral students, and teaching, for example at the clincial research schools hosted by the Clinical Epidemiologi Unit (Department of Medicine).

Since 2016 I have also been working as an overall project manager facilitating the scientific collaboration between Karolinska Institutet and Janssen Pharmaceuticals NV. The focus of this cooperation is the follow-up and effects of disease and treatment, using routine observational data from health care ("Real World Data"​) and how they relate to effects in clinical trials. The research areas include depression, prostate cancer, psoriasis, B-cell malignancies and statistical method development.

Education

PhD Medical Science, Karolinska Institutet (2013). 

Title of Thesis: Development and application of statistical methods for population-based cancer patient. (Supervisor: Paul Dickman).

MSc Mathematics, Uppsala University (2006). 

Publications

Hodgkin lymphoma in children, adolescents and young adults - a comparative study of clinical presentation and treatment outcome
Englund A, Glimelius I, Rostgaard K, Smedby Ke, Eloranta S, Molin D, et al
Acta oncologica (Stockholm, Sweden) 2018;57(2):276-282

Increasing incidence of primary central nervous system lymphoma but no improvement in survival in Sweden 2000-2013
Eloranta S, Brånvall E, Celsing F, Papworth K, Ljungqvist M, Enblad G, et al
European journal of haematology 2018;100(1):61-68

Prospective blinded surveillance screening of Swedish women with increased hereditary risk of breast cancer
Liljegren A, Von Wachenfeldt A, Azavedo E, Eloranta S, Grundström H, Ståhlbom Ak, et al
Breast cancer research and treatment 2018;168(3):655-666

Safety of fertility preservation in breast cancer patients in a register-based matched cohort study
Rodriguez-wallberg Ka, Eloranta S, Krawiec K, Lissmats A, Bergh J, Liljegren A
Breast cancer research and treatment 2018;167(3):761-769

Short- and long-term risks of cardiovascular disease following radiotherapy in rectal cancer in four randomized controlled trials and a population-based register
Chen L, Eloranta S, Martling A, Glimelius I, Neovius M, Glimelius B, et al
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2018;126(3):424-430

Simplicity at the cost of predictive accuracy in diffuse large B-cell lymphoma: a critical assessment of the R-IPI, IPI, and NCCN-IPI
Biccler J, Eloranta S, De Nully Brown P, Frederiksen H, Jerkeman M, Smedby Ke, et al
Cancer medicine 2018;7(1):114-122

Increased healthcare use up to 10 years among relapse-free Hodgkin lymphoma survivors in the era of intensified chemotherapy and limited radiotherapy
Glimelius I, Eloranta S, Ekberg S, Chang Et, Neovius M, Smedby Ke
American journal of hematology 2017;92(3):251-258

Parental Age and Risk of Lymphoid Neoplasms
Larfors G, Glimelius I, Eloranta S, Smedby Ke
AMERICAN JOURNAL OF EPIDEMIOLOGY 2017;186(10):1159-1167

Possible Interaction Between Cigarette Smoking and HLA-DRB1 Variation in the Risk of Follicular Lymphoma
Baecklund F, Foo Jn, Askling J, Eloranta S, Glimelius I, Liu J, et al
American journal of epidemiology 2017;185(8):681-687

Primary tumor sites in relation to ultraviolet radiation exposure and skin visibility correlate with survival in cutaneous melanoma
Gordon D, Hansson J, Eloranta S, Gordon M, Gillgren P, Smedby Ke
International journal of cancer 2017;141(7):1345-1354

Survival and level of care among breast cancer patients with brain metastases treated with whole brain radiotherapy
Frisk G, Tinge B, Ekberg S, Eloranta S, Bäcklund Lm, Lidbrink E, et al
Breast cancer research and treatment 2017;166(3):887-896

15-year follow-up of the Second Nordic Mantle Cell Lymphoma trial (MCL2): prolonged remissions without survival plateau
Eskelund Cw, Kolstad A, Jerkeman M, Räty R, Laurell A, Eloranta S, et al
British journal of haematology 2016;175(3):410-418

Mortality differences between self-employed and paid employees: a 5-year follow-up study of the working population in Sweden
Toivanen S, Griep Rh, Mellner C, Vinberg S, Eloranta S
Occupational and environmental medicine 2016;73(9):627-36

Pregnancy and the Risk of Relapse in Patients Diagnosed With Hodgkin Lymphoma
Weibull Ce, Eloranta S, Smedby Ke, Björkholm M, Kristinsson Sy, Johansson Al, et al
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2016;34(4):337-44

Work Loss Duration and Predictors Following Rectal Cancer Treatment among Patients with and without Prediagnostic Work Loss
Chen L, Glimelius I, Neovius M, Ekberg S, Martling A, Eloranta S, et al
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2016;25(6):987-94

Interactions Between High- and Low-Risk HPV Types Reduce the Risk of Squamous Cervical Cancer
Sundström K, Ploner A, Arnheim-dahlström L, Eloranta S, Palmgren J, Adami Ho, et al
Journal of the National Cancer Institute 2015;107(10):-

Long-term survival in young and middle-aged Hodgkin lymphoma patients in Sweden 1992-2009-trends in cure proportions by clinical characteristics
Glimelius I, Ekberg S, Jerkeman M, Chang Et, Björkholm M, Andersson Tm, et al
American journal of hematology 2015;90(12):1128-34

Risk and Cause of Death in Patients Diagnosed With Myeloproliferative Neoplasms in Sweden Between 1973 and 2005: A Population-Based Study
Hultcrantz M, Wilkes Sr, Kristinsson Sy, Andersson Tm, Derolf År, Eloranta S, et al
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2015;33(20):2288-95

Risk of disability pension in patients following rectal cancer treatment and surgery
Chen L, Glimelius I, Neovius M, Eloranta S, Ekberg S, Martling A, et al
The British journal of surgery 2015;102(11):1426-32

The impact of comorbid disease history on all-cause and cancer-specific mortality in myeloid leukemia and myeloma - a Swedish population-based study
Mohammadi M, Cao Y, Glimelius I, Bottai M, Eloranta S, Smedby Ke
BMC cancer 2015;15():850-

The loss in expectation of life after colon cancer: a population-based study
Andersson Tm, Dickman Pw, Eloranta S, Sjövall A, Lambe M, Lambert Pc
BMC cancer 2015;15():412-

Time trends in incidence of cutaneous melanoma by detailed anatomical location and patterns of ultraviolet radiation exposure: a retrospective population-based study
Gordon D, Gillgren P, Eloranta S, Olsson H, Gordon M, Hansson J, et al
Melanoma research 2015;25(4):348-56

Association of varying number of doses of quadrivalent human papillomavirus vaccine with incidence of condyloma
Herweijer E, Leval A, Ploner A, Eloranta S, Simard Jf, Dillner J, et al
JAMA 2014;311(6):597-603

Cancer incidence, survival and mortality: Explaining the concepts
Ellis L, Woods Lm, Esteve J, Eloranta S, Coleman Mp, Rachet B
INTERNATIONAL JOURNAL OF CANCER 2014;135(8):1774-82

Estimating the cure proportion of malignant melanoma, an alternative approach to assess long term survival: a population-based study
Andersson Tm, Eriksson H, Hansson J, Månsson-brahme E, Dickman Pw, Eloranta S, et al
Cancer epidemiology 2014;38(1):93-9

Hydatidiform mole and subsequent pregnancy outcome: a population-based cohort study
Joneborg U, Eloranta S, Johansson Al, Marions L, Weibull Ce, Lambe M
American journal of obstetrics and gynecology 2014;211(6):681.e1-7

Temporal trends in incidence of myocardial infarction and ischemic stroke by socioeconomic position in Sweden 1987-2010
Malki N, Koupil I, Eloranta S, Weibull Ce, Tiikkaja S, Ingelsson E, et al
PloS one 2014;9(8):e105279-

The application of cure models in the presence of competing risks: a tool for improved risk communication in population-based cancer patient survival
Eloranta S, Lambert Pc, Andersson Tm, Björkholm M, Dickman Pw
Epidemiology (Cambridge, Mass.) 2014;25(5):742-8

Childbearing and the risk of bladder cancer: a nationwide population-based cohort study
Weibull Ce, Eloranta S, Altman D, Johansson Al, Lambe M
European urology 2013;63(4):733-8

Estimating the loss in expectation of life due to cancer using flexible parametric survival models
Andersson Tm, Dickman Pw, Eloranta S, Lambe M, Lambert Pc
Statistics in medicine 2013;32(30):5286-300

How can we make cancer survival statistics more useful for patients and clinicians: an illustration using localized prostate cancer in Sweden
Eloranta S, Adolfsson J, Lambert Pc, Stattin P, Akre O, Andersson Tm, et al
Cancer causes & control : CCC 2013;24(3):505-15

Influence of radiotherapy for the first tumor on aggressiveness of contralateral breast cancer
Sandberg Me, Alkner S, Hartman M, Eloranta S, Rydén L, Ploner A, et al
International journal of cancer 2013;132(10):2388-94

Patterns of survival in lymphoplasmacytic lymphoma/Waldenström macroglobulinemia: a population-based study of 1,555 patients diagnosed in Sweden from 1980 to 2005
Kristinsson Sy, Eloranta S, Dickman Pw, Andersson Tm, Turesson I, Landgren O, et al
American journal of hematology 2013;88(1):60-5

Quadrivalent human papillomavirus vaccine effectiveness: a Swedish national cohort study
Leval A, Herweijer E, Ploner A, Eloranta S, Fridman Simard J, Dillner J, et al
Journal of the National Cancer Institute 2013;105(7):469-74

Reply to Silvia Selinski, Daniel Ovsiannikov, Jan G. Hengstler and Klaus Golka's Letter to the editor re: Caroline E. Weibull, Sandra Eloranta, Daniel Altman, Anna L.V. Johansson, Mats Lambe. Childbearing and the risk of bladder cancer: a nationwide population-based cohort study. Eur Urol 2013;63:733-8
Weibull Ce, Eloranta S, Johansson Al, Altman D, Lambe M
European urology 2013;64(4):e81-

[Structuring and documenting research projects]
Eloranta S, Johansson Al, Kristinsson Sy, Andersson Tm
Lakartidningen 2013;110(8):416-9

Temporal trends in mortality from diseases of the circulatory system after treatment for Hodgkin lymphoma: a population-based cohort study in Sweden (1973 to 2006)
Eloranta S, Lambert Pc, Sjöberg J, Andersson Tm, Björkholm M, Dickman Pw
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013;31(11):1435-41

Estrogen Receptor Status in Relation to Risk of Contralateral Breast Cancer-A Population-Based Cohort Study
Sandberg Mec, Hall P, Hartman M, Johansson Alv, Eloranta S, Ploner A, et al
PLOS ONE 2012;7(10):e46535-

Partitioning of excess mortality in population-based cancer patient survival studies using flexible parametric survival models
Eloranta S, Lambert Pc, Andersson Tm, Czene K, Hall P, Björkholm M, et al
BMC medical research methodology 2012;12():86-

Patterns of Survival Among Patients With Myeloproliferative Neoplasms Diagnosed in Sweden From 1973 to 2008: A Population-Based Study
Hultcrantz M, Kristinsson Sy, Andersson Tml, Landgren O, Eloranta S, Derolf Ar, et al
JOURNAL OF CLINICAL ONCOLOGY 2012;30(24):2995-3001

Prognostic implications of estrogen receptor pattern of both tumors in contralateral breast cancer
Sandberg Mec, Hartman M, Klevebring D, Eloranta S, Ploner A, Hall P, et al
BREAST CANCER RESEARCH AND TREATMENT 2012;134(2):793-800

Estimating and modelling cure in population-based cancer studies within the framework of flexible parametric survival models
Andersson Tml, Dickman Pw, Eloranta S, Lambert Pc
BMC MEDICAL RESEARCH METHODOLOGY 2011;:96-

Pancreatic cancer; reporting and long-term survival in Sweden
Lambe M, Eloranta S, Wigertz A, Blomqvist P
ACTA ONCOLOGICA 2011;50(8):1220-7

Reporting and incidence trends of hydatidiform mole in Sweden 1973-2004
Salehi S, Eloranta S, Johansson Alv, Bergstrom M, Lambe M
ACTA ONCOLOGICA 2011;50(3):367-72

Success Story of Targeted Therapy in Chronic Myeloid Leukemia: A Population-Based Study of Patients Diagnosed in Sweden From 1973 to 2008
Bjorkholm M, Ohm L, Eloranta S, Derolf A, Hultcrantz M, Sjoberg J, et al
JOURNAL OF CLINICAL ONCOLOGY 2011;29(18):2514-20

Vitamin D Receptor Genotypes, Ultraviolet Radiation Exposure, and Risk of Non-Hodgkin Lymphoma
Smedby Ke, Eloranta S, Duvefelt K, Melbye M, Humphreys K, Hjalgrim H, et al
AMERICAN JOURNAL OF EPIDEMIOLOGY 2011;173(1):48-54

Diagnostic work-up of contralateral breast cancers has not improved over calendar period
Sandberg Mec, Hartman M, Edgren G, Eloranta S, Ploner A, Hall P, et al
BREAST CANCER RESEARCH AND TREATMENT 2010;122(3):889-95

Does socioeconomic status influence the prospect of cure from colon cancer - A population-based study in Sweden 1965-2000
Eloranta S, Lambert Pc, Cavalli-bjorkman N, Andersson Tml, Glimelius B, Dickman Pw
EUROPEAN JOURNAL OF CANCER 2010;46(16):2965-72

Duration of red blood cell storage and survival of transfused patients (CME)
Edgren G, Kamper-jorgensen M, Eloranta S, Rostgaard K, Custer B, Ullum H, et al
TRANSFUSION 2010;50(6):1185-95

EFFECT OF ADJUVANT RADIOTHERAPY ON 2: D TUMOR CHARACTERISTICS AND PROGNOSIS OF CONTRALATERAL BREAST CANCER (CBC)
Sandberg Mec, Hartman M, Eloranta S, Ploner A, Hall P, Czene K
AMERICAN JOURNAL OF EPIDEMIOLOGY 2010;:S21-S21

Genetic variation in chromosomal translocation breakpoint and immune function genes and risk of non-Hodgkin lymphoma
Fernberg P, Chang Et, Duvefelt K, Hjalgrim H, Eloranta S, Sorensen Km, et al
CANCER CAUSES & CONTROL 2010;21(5):759-69

PATTERNS OF SURVIVAL AMONG 7,249 PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS DIAGNOSED IN SWEDEN 1973-2003
Hultcrantz L, Kristinsson S, Andersson T, Eloranta S, Derolf A, Landgren O, et al
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL 2010;:470-470

Prospective study of human papillomavirus and risk of cervical adenocarcinoma
Dahlstrom La, Ylitalo N, Sundstrom K, Palmgren J, Ploner A, Eloranta S, et al
INTERNATIONAL JOURNAL OF CANCER 2010;127(8):1923-30

Prospective Study of Human Papillomavirus (HPV) Types, HPV Persistence, and Risk of Squamous Cell Carcinoma of the Cervix
Sundstrom K, Eloranta S, Sparen P, Dahlstrom La, Gunnell A, Lindgren A, et al
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 2010;19(10):2469-78

Temporal trends in the proportion cured among adults diagnosed with acute myeloid leukaemia in Sweden 1973-2001, a population-based study
Andersson Tml, Lambert Pc, Derolf Ar, Kristinsson Sy, Eloranta S, Landgren O, et al
BRITISH JOURNAL OF HAEMATOLOGY 2010;148(6):918-24

Childbearing and Salivary Gland Cancer A Population-based Nested Case-control Study
Lu Yx, Lagergren J, Eloranta S, Lambe M
EPIDEMIOLOGY 2009;20(5):780-2

Mastitis and the Risk of Breast Cancer
Lambe M, Johansson Alv, Altman D, Eloranta S
EPIDEMIOLOGY 2009;20(5):747-51

Patterns of survival and causes of death following a diagnosis of monoclonal gammopathy of undetermined significance: a population-based study
Kristinsson Sy, Bjorkholm M, Andersson Tml, Eloranta S, Dickman Pw, Goldin Lr, et al
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL 2009;94(12):1714-20

PATTERNS OF SURVIVAL AND CAUSES OF DEATH FOLLOWING A DIAGNOSIS OF MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE: A POPULATION-BASED STUDY
Kristinsson Sy, Bjorkholm M, Andersson Tml, Eloranta S, Dickman Pw, Goldin Lr, et al
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL 2009;:157-157

Temporal Trends in the Proportion Cured Among Patients Diagnosed with Acute Myeloid Leukemia in Sweden 1973-2001, a Population-Based Study
Derolf Ar, Andersson Tml, Lambert Pc, Kristinsson Sy, Eloranta S, Landgren O, et al
BLOOD 2009;114(22):561-561

Mastitis and the risk of breast cancer - A population-based study (Sweden)
Lambe M, Johansson A, Altman D, Eloranta S
AMERICAN JOURNAL OF EPIDEMIOLOGY 2008;167(11):S90-S90

Placental weight and risk of invasive epithelial ovarian cancer with an early age of onset
Cnattingius S, Eloranta S, Adami Ho, Axelsson O, Dickman Pw, Hsieh Cc, et al
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 2008;17(9):2344-9

Show all publications